HLA-A*11:01&B2M&KRAS G12S (VVVGASGVGK) Tetramer, His & Avi, Human

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
GSC-Z06622-100	100 µg		-		7 - 10 business days*		1,505.00€
GSC-Z06622-500	500 µg		-		7 - 10 business days*		5,040.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in... more

Close menu

Product information "HLA-A*11:01&B2M&KRAS G12S (VVVGASGVGK) Tetramer, His & Avi, Human"

Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.

Keywords:	B2M, Beta-2-microglobulin
Supplier:	GenScript
Supplier-Nr:	Z06622

Properties

Conjugate:	No
Species reactivity:	human
MW:	258 kD
Purity:	>95% (Bis-Tris PAGE)

Database Information

KEGG ID :	K08055 \| Matching products
UniProt ID :	P61769 \| Matching products
Gene ID :	GeneID 567 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: °C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "HLA-A*11:01&B2M&KRAS G12S (VVVGASGVGK) Tetramer, His & Avi, Human"

Write a review